
MEDIGUS SP.ADR/15 IL-,01
Depository Receipt · US58471G4091 · XYLO · A3D1UP (XNCM)
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MEDIGUS SP.ADR/15 IL-,01
No Price
Company Profile for MEDIGUS SP.ADR/15 IL-,01 Depository Receipt
Xylo Technologies Ltd, a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops wireless vehicle battery charging technologies and modular electronic vehicles. The company was formerly known as Medigus Ltd. and changed its name to Xylo Technologies Ltd in April 2024. Xylo Technologies Ltd was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.
Company Data
Name MEDIGUS SP.ADR/15 IL-,01
Company Xylo Technologies Ltd.
Symbol XYLO
Website
https://www.medigus.com
Primary Exchange
Frankfurt
Frankfurt
WKN A3D1UP
ISIN US58471G4091
Asset Class Depository Receipt
Sector Healthcare
Industry Medical - Devices
CEO Liron Carmel
Market Capitalization 179 Mio
Country Israel
Currency EUR
Employees 0,0 T
Address 10 Hanechoshet, 6971072 Tel Aviv
IPO Date 2015-08-05
Dividends from 'MEDIGUS SP.ADR/15 IL-,01'
| Ex-Date | Dividend per Share |
|---|---|
| 19.12.2022 | 0,85 USD |
Stock Splits
| Date | Split |
|---|---|
| 05.08.2024 | 1:2.666666 |
| 14.11.2022 | 1:15 |
| 16.07.2018 | 1:4 |
| 15.03.2017 | 1:10 |
| 24.03.2008 | 1:2 |
ID Changes
| Date | From | To |
|---|---|---|
| 19.04.2024 | MDGS | XYLO |
Ticker Symbols
| Name | Symbol |
|---|---|
| Frankfurt | 2QM0.F |
| NASDAQ | MDGS |
| NASDAQ | XYLO |
More Shares
Investors who hold MEDIGUS SP.ADR/15 IL-,01 also have the following shares in their portfolio:
